Specialty Pharmacy Times
November 2011
Volume: 2
Issue: 4
August 2011
Volume: 2
Issue: 3
May 2011
Volume: 2
Issue: 2
February 2011
Volume: 2
Issue: 1
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Drives First-Line Immunotherapy Selection in NSCLC? Data, Payers, and Habit
2
FDA Grants Priority Review to Zanubrutinib Plus Rituximab for Previously Untreated MCL
3
AHA 2026: Insights on Oral PCSK9, Survodutide, and HF Care Come to Chicago
4
October Neurology News: Huntington Disease Gene Therapy, Remibrutinib in MS, and AI Medical Advice
5